We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Apple
AAPL
$4.47T
| $11.6M | 0.02% |
70,153
-1,608
| -2% | -$237K |
|
302
Liberty Broadband Class C
LBRDK
$5.18B
| $11.5M | 0.02% |
141,041
-10,432
| -7% | -$900K |
|
303
Employers Holdings
EIG
$873M
| $11.3M | 0.02% |
270,937
-2,344
| -0.9% | -$100K |
|
304
Pacira BioSciences
PCRX
$969M
| $11.2M | 0.02% |
273,816
-1,198,102
| -81% | -$47.7M |
|
305
Genco Shipping & Trading
GNK
$1.08B
| $11.1M | 0.02% |
711,096
-16,349
| -2% | -$280K |
|
|
SF
306
Stifel
SF
$12.7B
| $11M | 0.02% |
280,188
+23,140
| +9% | +$973K |
|
307
InMode
INMD
$879M
| $10.9M | 0.02% |
341,550
-5,174
| -1% | -$177K |
|
308
Chemed
CHE
$7.18B
| $10.9M | 0.02% |
+20,287
| New | +$10.3M |
|
|
ALE
309
DELISTED
Allete
ALE
| $10.7M | 0.02% |
166,502
-2,280
| -1% | -$143K |
|
310
First American
FAF
$7.37B
| $10.6M | 0.02% |
191,106
-14,083
| -7% | -$809K |
|
311
TTM Technologies
TTMI
$14B
| $10.6M | 0.02% |
782,798
-16,337
| -2% | -$236K |
|
312
Atkore
ATKR
$3.17B
| $10.4M | 0.02% |
73,695
-4,982
| -6% | -$675K |
|
313
El Paso Energy Capital Trust I
EP.PRC
$222M
| $10.1M | 0.02% |
+575,513
| New | +$26.3M |
|
|
CADE
314
DELISTED
Cadence Bank
CADE
| $10M | 0.02% |
+483,378
| New | +$12M |
|
315
Rexford Industrial Realty
REXR
$8.11B
| $9.93M | 0.02% |
166,514
-10,775
| -6% | -$645K |
|
316
Raymond James Financial
RJF
$34.6B
| $9.89M | 0.02% |
106,090
-9,182
| -8% | -$973K |
|
317
Moog Inc Class A
MOG.A
$13.1B
| $9.89M | 0.02% |
+98,162
| New | +$9.46M |
|
318
Charles River Laboratories
CRL
$13.3B
| $9.88M | 0.02% |
48,953
-8,991
| -16% | -$2.04M |
|
|
CSGS
319
DELISTED
CSG Systems International
CSGS
| $9.87M | 0.02% |
183,726
-3,702
| -2% | -$211K |
|
320
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $9.71M | 0.02% |
175,948
-8,243
| -4% | -$578K |
|
321
Alignment Healthcare
ALHC
$2.81B
| $9.69M | 0.02% |
1,523,531
-355,071
| -19% | -$3.39M |
|
322
Quanex
NX
$1B
| $9.65M | 0.02% |
448,101
-4,390
| -1% | -$105K |
|
323
Viavi Solutions
VIAV
$9.51B
| $9.63M | 0.02% |
889,296
-43,491
| -5% | -$474K |
|
|
CTLT
324
DELISTED
CATALENT, INC.
CTLT
| $9.63M | 0.02% |
146,501
-10,857
| -7% | -$671K |
|
325
WSFS Financial
WSFS
$4.14B
| $9.39M | 0.02% |
249,748
-6,348
| -2% | -$291K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.